X Monograph (Contd.): Index

Index

Page numbers followed by ‘n’, ‘r’ and ‘t’ denote footnote, reference and table respectively.

Abbott Labs 19

Abkhasians 17

About the Authors viii

About us iv

Abraham, Roy i

Abstract 19

Academia-Industry Symposium v, vii, xi, xiv, 11, 54

Activist would cozy with the man in black coat to go hunting for the one in white 31

Acute Intermittent Porphyria 5

Advertisement rates 60

Aggressive marketing of health services 15

AIDS epidemic, permissive morality and 16

Ajai Singh iii, vii, viii, ix, x, xi, 14, 19,

Akhtar, Salman 5-6

Akhtar Javed 6

A Larger than Life Persona who Makes People Feel Immediately at Ease 7-10

Write-up on Dr.Wig by Ravinder Kala 7-10

Alarming trend in the field of medicine 19, 20

All India Institute of Medical Sciences (AIIMS), New Delhi 1, 9

Alternative and Complementary Medicine 17-18

American and British Psychiatry 4

Angell M., (2004) 25, 50r

Anil V. Shah iii,iv

Anirudh Kala iii, iv, xi, 3, 6, 10

Write-up on Dr. Wig 3-6

Anything but Psychiatry 3

AstraZeneca 19

global sales fell by 0·6% in 2003. 25

stock prices extraordinarily volatile 25

settled criminal fraud charges of

US$ 355 million in case dealing with Zoladex 24

Augmentin, GlaxoSmithKline agreed to pay US $ 92 million to end law suits over 24

Bagadia, V.N. iii, iv,

Back issues 59

Bayer 19

settled over 2000 cases against its drug Baycol, at a cost of US $ 800 million 24

Baycol, Bayer settled over 2000 cases against it at cost of US $ 800 million 24

Bristol-Myers Squibb 19

grew by only 4·0% , 25

promised to pay US $ 300 million to fend off a lawsuit by its own shareholders 24

British Psychiatry, American and 4

Mens Sana Monographs, III,4-5, Nov. 2005-Feb. 2006 61

Business or Professional Ethics in Medicine 20

Busy hijacking medicine and its research agenda, Pharma Industry 25

Call for Papers: What medicine means to me x

Call for Poems in MSM Poems Section on Medicine, Health and Human Behaviour 52

Change focus from treatment to prevention 17

Changing fashions in the world of disease 16

Choice between the expedient and the ideal 40

Clinical tradition, difference between UK and US 4

Complementary Medicine, Alternative and 17-18

Colourful T shirts, Prof Wig and 10

Community Mental Health work 9

Raipur Rani Block, Community Mental Health Model 1,4,9

Complementing Approaches, Developing Therapies, Emphasising Prevention 15-18

Complementary Medicine and Religious Spirituality and Practices, Preventive Medicine, for disease prevention 18

Concluding Remarks 48-50

Conferences in Five Star hotels 21

Contents xi-xii

Contributors, Instructions to vi

Corporate Enterprise, Medicine as a 20, 34-37, 49

Crores for a Conference, Millions for a Mid-Term 19, 21, 48

CSE (Council of Science Editors) guidelines (Editorial Policy Statements), vi

Curtail the processes that germinate and bolster disease 17

Datamonitor Newswire (2005), 24, 50r

Decide which side to be on 47-48

Dedication to Dr. N.N. Wig xiii

Developing Therapies, Complementing Approaches, Emphasising Prevention and 15-18

Difference between UK and US

Clinical tradition 4

Death as the culmination of a life led fully and well 18

Death postponed 15

Disability curtailed 15

Disease free, Living 17

Disease prevention level 18

Trinity of Preventive Medicine, Complementary Medicine and Religious Spirituality and Practices 18

Disease treatment level 18

Distress ameliorated 15

Docs

for pharma to place a voluntary cut on junkets and trinkets 13

like some feudal lords of yester years 13

no option but to pamper 13

to expect less pampering 13

Drug research

one after 5000 to 10000 promising ones have had to be shelved 22

new, from laboratory to pharmacy shelf after 12 to 13 years 22

new medicine carries within a contribution towards cost of discovering next 23

research driven pharmaceutical companies invest about 20% of sales in R and D 22

Drug trials,

getting pliant researchers into 20

manipulation of 20

Dube, Prof. K.C. 5

Eclectic Resolution 20, 40, 49

Editorial 15-18

Abkhasians 17

aggressive marketing of health services 15

Alternative and Complementary Medicine 17-18

62 Mens Sana Monographs, III,4-5, Nov. 2005-Feb. 2006

change focus from treatment to prevention 17

changing fashions in the world of disease 16

curtail the processes that germinate and bolster disease 17

death as the culmination of a life led fully and well 18

death postponed 15

disability curtailed 15

Distress has been ameliorated 15

Emphasising Prevention, Developing Therapies, Complementing Approaches 15-18

Innovation in medicine 15

kaleidoscope of disease 16-17

living disease free 17

mass destruction due to external calamities 16

naïve to believe that medicine will capture disease 16

origin of disease, stemming, not attractive proposition 17

patient population has not reduced 15

permissive morality and AIDS epidemic 16

Preventive and Social Medicine 17

religion and spirituality in disease reduction/prevention 18

sicknesses not reducing in number, changing in type 15

sicknesses, upsurge in 16

technology to ameliorate disease 17

terrorist attacks using modern technology on inimical civilizations 16

Editorial correspondence MSM iii

EFPIA (See also drug research) 21-22, 50r

Email of Mens Sana Monographs

mensanamonographs@yahoo.co.uk

Emphasising Prevention, Developing Therapies, Complementing Approaches( See editorial)

Enough of portraying also-rans as champions 29

Enough of suppressing adverse effects 29

External calamities like earthquakes, floods, tsunamis and hurricanes 16

Financial Condition of Pharma Majors on the Decline 25

Garg U. C. i

Gastronomy of excited medics 20

General Hospital Psychiatry Movement 3-4

George E. Vaillant iii, iv

GlaxoSmithKline 19

agreed to pay US $ 2.5 million for charges that it suppressed findings that showed its antidepressant, Paxil, was harmful in children 24

agreed to pay US $ 92 million to end law suits over Augmentin, its antibiotic 24

grew by only 3·9% , 25

paid $75 million for allegedly overcharging patients and insurers for its anti-inflammatory drug, Relafen 24

stock prices extraordinarily volatile 25

Go for the real champions, Pharma should 29

“Good Afternoon!” 8

Guidelines (Editorial Policy Statements), CSE (The Council of Science Editors) vi

Guidelines (URM: Uniform Requirements for Manuscripts) , ICMJE vi

Handsome man with a warm smile, Dr. Wig 7

Harris G., (2004a), 24, 50r

Harris G., (2004b), 24, 50r

Harvallabh festival of classical music 10

Honorary International Advisory Board of Mens Sana Monographs iii

Welcome to iv

http:/mensanamonographs.tripod.com iii, vi, viii, x

Horton R. (2004a), 25, 50r

Horton R. (2004b), 25, 50r

Hypomania and hysterical fits 5

Mens Sana Monographs, III,4-5, Nov. 2005-Feb. 2006 63

ICMJE Guidelines (URM: Uniform Requirements for Manuscripts) vi

Increased R and D spending, Price deflation, litigation costs and 19, 27-28, 48

Index 61

Indian Pharma Industry 31-32

captains 19-20

lawsuits against Indian pharmaceuticals bound to go up 31

would soon start running up huge compensation bills 31

Indian Psychiatric Society i

Innovation in medicine 15

Instructions to Contributors vi

Introduction 20

Javed Akhtar 6

Jhatka, nothing works better to reorient thinking than a big 29

Journal Editors, manipulation of 20

Junkets and Trinkets 13

like some feudal lords of yester years 13

Musings 13

no option but to pamper 13

to expect less pampering 13

pharma to place a voluntary cut on junkets and trinkets 13

voluntary moratorium on spending by pharma 14

Kala Anirudh K. iii, iv, xi, 3, 6, 10

Write-up on Dr. Wig 3-6

Kala Ravinder 7, 10

Write-up on Dr. Wig 7-10

Kaleidoscope of disease 16-17

Lame duck, Big Pharma Industry a, 28

Law suits against industry 20, 23

careful not to overbalance 30

ominous portents 23

patients no longer ready to buy the patient welfare bait 30

silver lining 30

remedy the tilt in academia-industry relationship 30

what did they indicate? 30-31

would affect company bottom lines 31

Law suits against GlaxoSmithKline, Bayer, Pfizer, Bristol-Myers Squibb, AstraZeneca, Schering-Plough, Abbott Labs, TAP Pharmaceuticals, Wyeth, Merck 24-25

Life Subscription viii, 53

Like some feudal lords of yester years,

Docs 13

Litigation costs Increased R and D spending, Price deflation, and 19, 27-28

Long term Measures 20, 33-34,

medicine is to become a corporate enterprise 20

patient welfare centered professional enterprise 20

remain a patient welfare centered profession. 20

Long term measures to forward patient welfare agenda ix, 20, 33-48, 49

Lipitor, Pfizer sued at present by consumer groups over 24

Living disease free 17

Lupron, US $ 290 million in criminal fines, plus US $ 585 million in civil penalties 25

(Contd.)